MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

30 May 2023 Evaluate
The sales moved up 42.65% to Rs. 293.27 millions for the March 2023 quarter as compared to Rs. 205.58 millions during the year-ago period.Profit after tax for the quarter ended March 2023 reported a huge growth of 52.87% to Rs. 58.67  millions from Rs. 38.38 millions.Operating profit surged to 87.01 millions from the corresponding previous quarter of 57.83 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 293.27 205.58 42.65 902.20 712.88 26.56 902.20 712.88 26.56
Other Income 4.37 11.37 -61.57 31.65 35.68 -11.29 31.65 35.68 -11.29
PBIDT 87.01 57.83 50.46 264.24 214.88 22.97 264.24 214.88 22.97
Interest 0.40 0.15 166.67 1.16 1.46 -20.55 1.16 1.46 -20.55
PBDT 86.61 57.68 50.16 263.08 213.42 23.27 263.08 213.42 23.27
Depreciation 10.28 5.80 77.24 37.24 33.37 11.60 37.24 33.37 11.60
PBT 76.33 51.88 47.13 225.84 180.05 25.43 225.84 180.05 25.43
TAX 17.66 13.50 30.81 55.64 46.07 20.77 55.64 46.07 20.77
Deferred Tax -2.33 -0.02 11550.00 -2.84 -0.39 628.21 -2.84 -0.39 628.21
PAT 58.67 38.38 52.87 170.20 133.98 27.03 170.20 133.98 27.03
Equity 125.11 120.07 4.20 125.11 120.07 4.20 125.11 120.07 4.20
PBIDTM(%) 29.67 28.13 5.47 29.29 30.14 -2.83 29.29 30.14 -2.83
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..